This page is part of the International Patient Summary Implementation Guide (v1.0.0: STU 1) based on FHIR R4. The current version which supercedes this version is 1.1.0. For a full list of available versions, see the Directory of published versions
Summary
Defining URL: | http://hl7.org/fhir/uv/ips/ValueSet/results-pathology-observations-uv-ips |
Version: | 1.0.0 |
Name: | ResultsPathObservationUvIps |
Status: | Active |
Title: | Results Pathology Observation - IPS |
Definition: | Value Set Definition: LOINC {STATUS in {ACTIVE}, CLASSTYPE in {1}, CLASS in {CYTO, HL7.CYTOGEN, HL7.GENETICS, MOLPATH, MOLPATH.*, PATH, PATH.*}} |
Publisher: | Health Level Seven International - Patient Care Work Group |
Copyright: | This artifact includes content from LOINC®. LOINC codes are copyright Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Terms & Conditions in https://loinc.org/license/ |
Source Resource: | XML / JSON / Turtle |
References
http://loinc.org
where STATUS = ACTIVE, CLASSTYPE = 1 and CLASS matches (by regex) CYTO|HL7\.CYTOGEN|HL7\.GENETICS|^PATH(\..*)?|^MOLPATH(\..*)?
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Expansion based on Loinc v2.66 (Jun 2019)
All codes from system http://loinc.org
Code | Display |
10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain |
10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain |
10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain |
10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain |
10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain |
10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain |
10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain |
10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain |
10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain |
10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain |
10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain |
10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain |
10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain |
10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain |
10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain |
10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain |
10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain |
10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain |
10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain |
10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain |
10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain |
10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain |
10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain |
10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain |
10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
10861-3 | Progesterone receptor [Mass/mass] in Tissue |
11016-3 | Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific |
11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain |
11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
11270-6 | Viral inclusion bodies [Identifier] in Unspecified specimen by Cyto stain |
11552-7 | Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology |
11553-5 | Microscopic exam [Interpretation] of Sputum by Cytology |
13531-9 | Fat.microscopic observation [Presence] in Sputum by Sudan III stain |
13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
14130-9 | Estrogen receptor [Moles/mass] in Tissue |
14228-1 | Cells.estrogen receptor/100 cells in Tissue by Immune stain |
14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain |
14230-7 | Cells.progesterone receptor/100 cells in Tissue by Immune stain |
15211-6 | Biopsy [Interpretation] in Thyroid Narrative |
15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain |
16112-5 | Estrogen receptor [Interpretation] in Tissue |
16113-3 | Progesterone receptor [Interpretation] in Tissue |
16856-7 | Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain |
18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain |
18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain |
18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
19102-3 | Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
19762-4 | General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
19763-2 | Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
19764-0 | Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
19766-5 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative |
19767-3 | Cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
19768-1 | Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
19769-9 | Pathologist who read Cyto stain of Cervical or vaginal smear or scraping |
19771-5 | Screening techniques [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
19772-3 | Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain |
19773-1 | Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
19774-9 | Cytology study comment Cervical or vaginal smear or scraping Cyto stain |
20990-8 | APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21024-5 | Pathologist interpretation of Cerebral spinal fluid tests |
21025-2 | Pathologist interpretation of Body fluid tests |
21026-0 | Pathologist interpretation of Blood tests |
21081-5 | ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21095-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21176-3 | Cerebroventricular lining cells [Presence] in Cerebral spinal fluid by Light microscopy |
21207-6 | CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21391-8 | Microscopic observation [Identifier] in Bone by Acid phosphatase stain |
21551-7 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21614-3 | CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
21615-0 | CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
21617-6 | APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method |
21618-4 | APC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21619-2 | APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21620-0 | STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
21622-6 | ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method |
21623-4 | ASPA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21624-2 | ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21625-9 | ATM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21626-7 | ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21627-5 | ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method |
21628-3 | ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method |
21629-1 | ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method |
21630-9 | ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method |
21631-7 | ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method |
21632-5 | ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method |
21633-3 | ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method |
21634-1 | ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method |
21635-8 | ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method |
21636-6 | BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21637-4 | BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
21638-2 | BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
21639-0 | BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21640-8 | BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
21641-6 | CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21642-4 | CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method |
21643-2 | CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method |
21644-0 | CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method |
21645-7 | CACNA1S gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21646-5 | CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21649-9 | CBS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21651-5 | CCR5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21652-3 | CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21653-1 | CDH1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21654-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21655-6 | CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method |
21656-4 | CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21657-2 | COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21658-0 | COL2A1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21659-8 | CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21660-6 | CTNNB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21661-4 | CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21662-2 | CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method |
21663-0 | CYP2D6 gene G-A NT1 X4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21664-8 | CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method |
21665-5 | EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21666-3 | EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21668-9 | F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method |
21669-7 | F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21670-5 | F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21671-3 | F7 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21672-1 | F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21673-9 | F8 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21674-7 | FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21675-4 | FGFR2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21676-2 | FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21677-0 | FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method |
21678-8 | FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method |
21679-6 | FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method |
21680-4 | G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21681-2 | G6PD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21682-0 | Gaucher 1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21683-8 | Gaucher 2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21684-6 | Gaucher 3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21685-3 | HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21686-1 | HADHB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21687-9 | HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21688-7 | HBA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21689-5 | HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21690-3 | HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method |
21691-1 | HBB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21692-9 | PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21693-7 | HP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21694-5 | HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21695-2 | HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method |
21696-0 | HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method |
21697-8 | HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21698-6 | HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21699-4 | HRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21700-0 | Kallman syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21701-8 | Kallman syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21702-6 | KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21703-4 | KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21704-2 | MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21705-9 | MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method |
21707-5 | MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method |
21709-1 | MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21712-5 | MTHFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21713-3 | MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method |
21714-1 | MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method |
21715-8 | MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21718-2 | NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21720-8 | NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21721-6 | OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21722-4 | OTC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21723-2 | SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21724-0 | SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method |
21725-7 | SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method |
21726-5 | SERPINA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21727-3 | PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21728-1 | PMP22 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21729-9 | PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21730-7 | PSAP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21731-5 | RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21732-3 | RB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21733-1 | RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21734-9 | RET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21735-6 | SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21736-4 | SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method |
21737-2 | SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method |
21738-0 | SNCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21739-8 | TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21740-6 | TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21741-4 | TRAF3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21742-2 | WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
21743-0 | WT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21744-8 | CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21746-3 | BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21747-1 | HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21748-9 | Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21749-7 | Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21750-5 | MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21751-3 | TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21752-1 | TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21753-9 | TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
21754-7 | AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21755-4 | CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21756-2 | ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21759-6 | FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21760-4 | FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21762-0 | FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method |
21763-8 | HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21764-6 | MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21765-3 | SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21766-1 | SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21767-9 | SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21768-7 | SCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
21769-5 | SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
21770-3 | Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics |
21771-1 | Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics |
21772-9 | Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics |
21773-7 | Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics |
21774-5 | Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics |
21775-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21776-0 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21777-8 | t(11;14)(q13;q32)(CCND1,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21778-6 | t(11;19)(q23;p13.3)(MLL,MLLT1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21779-4 | t(11;22)(q24;q12.2)(FLI1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21780-2 | t(11;22)(p13;q12.2)(WT1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21781-0 | t(12;16)(q13;p11.2)(DDIT3,FUS) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21782-8 | t(12;21)(p13;q22.3)(ETV6,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21783-6 | t(12;22)(q13;q12.2)(ATF1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21784-4 | t(14;18)(q32;q21.3)(IGH,BCL2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21785-1 | t(15;17)(q24.1;q21.1)(PML,RARA) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21786-9 | t(2;13)(q36.1;q14.4)(PAX3,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21787-7 | t(2;5)(p23;q35.1)(ALK,NPM1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21788-5 | t(21;22)(q22.3;q12.2)(ERG,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21789-3 | t(4;11)(q21.3;q23)(AFF1,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21790-1 | t(5;12)(q33.1;p13)(PDGFRB,ETV6) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21791-9 | t(6;9)(p22;q34)(DEK,NUP214) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21792-7 | t(8;14)(q24;q32)(MYC,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21793-5 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21794-3 | t(9;11)(p22;q23)(MLLT3,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21795-0 | t(9;22)(q34.1;q11)(ABL1,BCR) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21796-8 | t(9;22)(q22;q12.2)(NR4A3,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21797-6 | t(X;18)(q11.2;p11.23)(SS18,SSX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21798-4 | t(X;18)(q11.2;p11.22)(SS18,SSX2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
21799-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21800-8 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21801-6 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21802-4 | t(11;19)(q23;p13.3)(MLL,MLLT1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21803-2 | t(11;22)(q24;q12.2)(FLI1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21804-0 | t(11;22)(p13;q12.2)(WT1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21805-7 | t(12;16)(q13;p11.2)(DDIT3,FUS) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21806-5 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21807-3 | t(12;22)(q13;q12.2)(ATF1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21808-1 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21809-9 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
21810-7 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
21812-3 | t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21813-1 | t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21814-9 | t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21815-6 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21816-4 | t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21817-2 | t(6;9)(p22;q34)(DEK,NUP214) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21818-0 | t(8;14)(q24;q32)(MYC,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21819-8 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21820-6 | t(9;11)(p22;q23)(MLLT3,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21821-4 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21822-2 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
21823-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
21824-8 | t(9;22)(q22;q12.2)(NR4A3,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21825-5 | t(X;18)(q11.2;p11.23)(SS18,SSX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
21826-3 | t(X;18)(q11.2;p11.22)(SS18,SSX2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
22066-5 | PRSS1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
22067-3 | NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
22068-1 | MXI1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
22069-9 | MT-ATP6 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
22070-7 | HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
22071-5 | Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
22072-3 | Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
22073-1 | Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
22074-9 | FGFR3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
22075-6 | DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
24475-6 | F2 gene c.20210G>A [Presence] in Blood or Tissue by Molecular genetics method |
24476-4 | F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
24477-2 | F2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
27045-4 | Microscopic exam [Interpretation] of Urine by Cytology |
27984-4 | SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
28005-7 | MTHFR gene c.677C>T [Presence] in Blood or Tissue by Molecular genetics method |
28060-2 | MTHFR gene c.1298A>C [Presence] in Blood or Tissue by Molecular genetics method |
29540-2 | E-cadherin [Presence] in Tissue by Immune stain |
29770-5 | Karyotype [Identifier] in Blood or Tissue Nominal |
29863-8 | IgD Ag [Presence] in Tissue by Immune stain |
30005-3 | CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
30080-6 | Cathepsin D [Presence] in Tissue by Immune stain |
30911-2 | DNA ploidy [Identifier] in Unspecified specimen by Flow cytometry (FC) Nominal |
30912-0 | DNA index in Unspecified specimen by Flow cytometry (FC) |
30913-8 | S-phase cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
30914-6 | Hyperdiploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
30915-3 | Aneuploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
30916-1 | Euploid+Aneuploid cells/100 cells in Unspecified specimen |
30917-9 | DNA ploidy [Interpretation] in Unspecified specimen by Flow cytometry (FC) Narrative |
31114-2 | Aneuploid cell population 1/100 cells in Unspecified specimen |
31115-9 | Aneuploid cell population 2/100 cells in Unspecified specimen |
31116-7 | Euploid+Aneuploid cells population 1/100 cells in Unspecified specimen |
31117-5 | Euploid+Aneuploid cells population 2/100 cells in Unspecified specimen |
31118-3 | G2+M phase cells/100 cells in Unspecified specimen |
31149-8 | P53 protein Ag/100 cells in Tissue by Immune stain |
31150-6 | HER2 [Presence] in Tissue by FISH |
31187-8 | Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain |
31188-6 | Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain |
31189-4 | Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain |
31190-2 | Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain |
31191-0 | Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain |
31192-8 | Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain |
31193-6 | Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain |
31194-4 | Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain |
31195-1 | Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain |
31196-9 | Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain |
31197-7 | Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain |
31198-5 | Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain |
31199-3 | Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain |
31207-4 | Progesterone receptor [Moles/mass] in Tissue |
32151-3 | Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method |
32581-1 | Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain |
32628-0 | ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method |
32630-6 | MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32632-2 | HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32639-7 | FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32640-5 | BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32641-3 | SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32653-8 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
32785-8 | Microscopic observation [Identifier] in Unspecified specimen by Non-gynecological cytology method |
32798-1 | Microscopic observation [Identifier] in Unspecified specimen by Oil red O stain |
32812-0 | Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain |
32813-8 | Pathologist interpretation of Bronchial specimen tests |
32814-6 | Microscopic observation [Identifier] in Unspecified specimen by Chloracetate esterase stain |
32815-3 | Microscopic observation [Identifier] in Unspecified specimen by Sudan black B stain |
32816-1 | Microscopic observation [Identifier] in Unspecified specimen by Terminal deoxynucleotidyl transferase stain |
32817-9 | Microscopic observation [Identifier] in Unspecified specimen by Myeloperoxidase stain |
32818-7 | Microscopic observation [Identifier] in Unspecified specimen by Acetate esterase stain |
32824-5 | Microscopic observation [Identifier] in Unspecified specimen by Tartrate-resistant acid phosphatase stain |
32996-1 | HER2 [Mass/volume] in Serum |
33054-8 | BCL2 Ag [Presence] in Tissue by Immune stain |
33675-0 | Microscopic observation [Identifier] in Unspecified specimen by Esterase stain.combined |
33718-8 | Cytology report of Tissue fine needle aspirate Cyto stain |
33723-8 | Specimen length |
33724-6 | Collection method - |
33725-3 | Tumor site |
33726-1 | Macroscopic tumor configuration |
33728-7 | Size.maximum dimension in Tumor |
33729-5 | Size additional dimension in Tumor |
33730-3 | Resection completeness in Mesorectum Qualitative by Macroscopy |
33731-1 | Histology type in Cancer specimen Narrative |
33732-9 | Histology grade [Identifier] in Cancer specimen |
33733-7 | Sites of distant metastasis |
33734-5 | Surgical margin tumor involvement.proximal by CAP cancer protocols |
33735-2 | Surgical margin tumor involvement.distant by CAP cancer protocols |
33736-0 | Surgical margin tumor involvement.circumferential by CAP cancer protocols |
33737-8 | Distance of tumor from closest margin |
33738-6 | Closest margin |
33739-4 | Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
33740-2 | Venous.large vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
33742-8 | Tumor border configuration [Type] in Specimen |
33746-9 | Pathologic findings |
33747-7 | Number of fragmented pieces |
33748-5 | Distance from anal verge |
33751-9 | Surgical margin tumor involvement.lateral in Specimen by CAP cancer protocols |
33752-7 | Distance of carcinoma from closest lateral margin [Length] in Specimen |
33754-3 | Surgical margin tumor involvement.deep in Specimen by CAP cancer protocols Narrative |
33755-0 | Distance of carcinoma from deep margin [Length] in Specimen |
33756-8 | Polyp size greatest dimension |
33757-6 | Polyp size additional dimensions |
33758-4 | Polyp stalk length by CAP cancer protocols |
33759-2 | Deepest extent of invasion [Type] in Specimen |
33760-0 | Surgical margin tumor involvement.mucosal in Specimen by CAP cancer protocols |
33761-8 | Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols |
33773-3 | Karyotype [Identifier] in Amniotic fluid Nominal |
33774-1 | Karyotype [Identifier] in Chorionic villus sample Nominal |
33779-0 | IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain |
33893-9 | Karyotype [Identifier] in Bone marrow Nominal |
33981-2 | TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
34122-2 | Pathology procedure note |
34193-3 | SMPD1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
34203-0 | SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
34489-5 | TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
34490-3 | MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34491-1 | PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34492-9 | NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34493-7 | PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
34494-5 | SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method |
34495-2 | TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34496-0 | Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
34497-8 | SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34498-6 | ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34499-4 | GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34500-9 | SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34501-7 | HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
34502-5 | VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34503-3 | Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
34504-1 | GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34505-8 | NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34506-6 | EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34507-4 | PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34508-2 | PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34509-0 | UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34510-8 | SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34511-6 | SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34512-4 | NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34513-2 | NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method |
34514-0 | SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34515-7 | GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34516-5 | SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34517-3 | CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34518-1 | SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34519-9 | HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34600-7 | HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
34647-8 | PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34649-4 | MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34650-2 | TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34651-0 | CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34653-6 | GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34654-4 | MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34656-9 | KEL gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
34658-5 | MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
34659-3 | ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34675-9 | Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34678-3 | MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method |
34679-1 | PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34681-7 | Biopsy [Interpretation] in Muscle Narrative |
34698-1 | CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34706-2 | CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method |
34718-7 | CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
34722-9 | EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
34727-8 | DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
34729-4 | CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method |
34730-2 | Chromosome breakage [Interpretation] in Unspecified specimen |
34731-0 | APOE gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method |
34732-8 | APOE gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method |
34739-3 | NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34740-1 | NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
34741-9 | RHCE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
34742-7 | Chromosome breakage [Units/volume] in Blood by Diepoxybutane |
34819-3 | Pathology Evaluation and management note |
34972-0 | DNA index 3 in Unspecified specimen by Flow cytometry (FC) |
34973-8 | DNA index 2 in Serum or Plasma by Flow cytometry (FC) |
34974-6 | DNA index 3 in Serum or Plasma by Flow cytometry (FC) |
34975-3 | DNA index in Serum or Plasma by Flow cytometry (FC) |
34976-1 | DNA index 2 in Unspecified specimen by Flow cytometry (FC) |
35122-1 | MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35123-9 | Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
35129-6 | Karyotype [Identifier] in Unspecified specimen Nominal |
35132-0 | MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35137-9 | MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35138-7 | MEFV gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
35265-8 | Pathology report addendum in Specimen Narrative |
35266-6 | Gleason score in Specimen Qualitative |
35267-4 | Age at pathology Dx |
35288-0 | MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35290-6 | RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35291-4 | UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
35292-2 | Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
35293-0 | TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35294-8 | PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35295-5 | BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35296-3 | PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35297-1 | LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35298-9 | FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35299-7 | PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35300-3 | GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35302-9 | HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35304-5 | CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35306-0 | TTR gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35307-8 | TTR gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35324-3 | PMP22 gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
35325-0 | PMP22 gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
35340-9 | ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method |
35341-7 | ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method |
35351-6 | Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35353-2 | FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35354-0 | COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35355-7 | PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35356-5 | TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35357-3 | PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35358-1 | LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35359-9 | AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35366-4 | SCA2 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35367-2 | SCA2 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35368-0 | SCA1 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35369-8 | SCA1 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35372-2 | GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method |
35374-8 | DMPK gene allele 2 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35375-5 | DMPK gene allele 1 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35376-3 | MJD gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35377-1 | MJD gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
35378-9 | HNPCC genes mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
35379-7 | HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35380-5 | HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
35381-3 | HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method |
35382-1 | HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method |
35453-0 | ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35454-8 | MLL gene rearrangements in Blood or Tissue by Molecular genetics method |
35455-5 | X chromosome inactivation [Identifier] in Blood or Tissue Narrative |
35456-3 | Y chromosome deletion [Identifier] in Blood or Tissue Nominal |
35457-1 | Maternal cell contamination [Identifier] in Amniotic fluid Nominal |
35461-3 | ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35462-1 | SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35463-9 | Telomere analysis [Identifier] in Blood or Tissue Nominal |
35464-7 | CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35465-4 | RHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35466-2 | AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35470-4 | Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35472-0 | HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method |
35473-8 | HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method |
35474-6 | Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35506-5 | Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35645-1 | NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
35686-5 | GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method |
35687-3 | GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method |
35688-1 | GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method |
35689-9 | GBA gene c.84insG [Presence] in Blood or Tissue by Molecular genetics method |
35690-7 | GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method |
35692-3 | G0+G1 phase cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
35693-1 | GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35737-6 | Microscopic observation [Identifier] in Amniotic fluid by Nile blue prusside |
35742-6 | SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35744-2 | TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
35749-1 | DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method |
35750-9 | DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
35751-7 | DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
35753-3 | Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
35864-8 | Chronic lymphocytic leukemia gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36907-4 | Chromosome 8 trisomy [Percentile] by Cytogenetics |
36908-2 | Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36909-0 | G0+G1 phase cells/100 cells in Blood |
36910-8 | S-phase cells/100 cells in Blood |
36911-6 | SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
36912-4 | CATCH22 syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36913-2 | FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
36914-0 | FMR1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36915-7 | AS+PWS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36917-3 | Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
36918-1 | ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
36919-9 | ELN gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
36920-7 | PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
36922-3 | TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
36925-6 | MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38179-8 | Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38380-2 | HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method |
38404-0 | CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38405-7 | MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38406-5 | PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38407-3 | PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38408-1 | PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38409-9 | SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38411-5 | TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38412-3 | FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38413-1 | FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38415-6 | MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38447-9 | CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
38448-7 | CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method |
38449-5 | CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method |
38450-3 | CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method |
38451-1 | CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method |
38452-9 | CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
38453-7 | CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method |
38454-5 | CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method |
38455-2 | CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
38456-0 | CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method |
38471-9 | Karyotype [Identifier] in Urine Nominal |
38529-4 | CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38530-2 | BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38531-0 | BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
38532-8 | SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38533-6 | TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38534-4 | COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38535-1 | LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38536-9 | MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38537-7 | ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38550-0 | MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38891-8 | ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38895-9 | ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38896-7 | F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38900-7 | HEXA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
38902-3 | LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38904-9 | MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38905-6 | MLL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
38906-4 | MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38907-2 | NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38909-8 | PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38911-4 | SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38913-0 | TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38914-8 | RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38918-9 | ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38919-7 | LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38920-5 | MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38921-3 | MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38922-1 | PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38923-9 | SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38924-7 | TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38925-4 | RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38927-0 | TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38928-8 | FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
38929-6 | FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38930-4 | EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
38931-2 | TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
39004-7 | Epidermal growth factor receptor Ag [Presence] in Tissue |
39080-7 | EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
39086-4 | Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep |
39089-8 | PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
39575-6 | Fungus.microscopic observation [Identifier] in Unspecified specimen by Periodic acid-Schiff stain |
40341-0 | MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method |
40342-8 | MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method |
40343-6 | MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method |
40345-1 | MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method |
40346-9 | MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method |
40347-7 | MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method |
40348-5 | MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method |
40349-3 | MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method |
40350-1 | MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method |
40351-9 | MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method |
40352-7 | MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method |
40353-5 | MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method |
40354-3 | MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method |
40425-1 | CYP2D6 gene mutations found [Identifier] in Blood, Tissue or Saliva by Molecular genetics method Nominal |
40426-9 | FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40427-7 | FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40428-5 | NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40429-3 | NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40430-1 | TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40434-3 | APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40461-6 | GJB1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40462-4 | GJB1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40463-2 | TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40468-1 | SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40471-5 | FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40475-6 | WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40476-4 | PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40477-2 | L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40478-0 | MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain |
40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain |
40558-9 | Cytokeratin 20 Ag [Presence] in Tissue by Immune stain |
40559-7 | Cytokeratin 7 Ag [Presence] in Tissue by Immune stain |
40560-5 | Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain |
40561-3 | Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain |
40562-1 | Actin muscle specific Ag [Presence] in Tissue by Immune stain |
40563-9 | Actin smooth muscle Ag [Presence] in Tissue by Immune stain |
40564-7 | Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain |
40693-4 | RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40704-9 | Maternal cell contamination [Identifier] in Blood Nominal |
40833-6 | SOD1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40859-1 | SOD1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40871-6 | CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40872-4 | CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method |
40873-2 | CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method |
40876-5 | AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method |
40877-3 | CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method |
40878-1 | CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method |
40930-0 | PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method |
40959-9 | MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40961-5 | SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40962-3 | SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
40970-6 | VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40994-6 | CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
40995-3 | Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41042-3 | WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41043-1 | VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41044-9 | UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41045-6 | TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41046-4 | TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41047-2 | TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41048-0 | TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41049-8 | TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41050-6 | TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41051-4 | SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41052-2 | SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41053-0 | SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41055-5 | SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41056-3 | SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41057-1 | SHOX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41058-9 | SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41059-7 | SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41060-5 | SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41061-3 | SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41062-1 | SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41063-9 | RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41064-7 | PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41065-4 | PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41066-2 | PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41067-0 | PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
41068-8 | PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41069-6 | PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41070-4 | Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41071-2 | PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41072-0 | PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41073-8 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41074-6 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal |
41075-3 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41076-1 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41077-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41078-7 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41079-5 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41080-3 | Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41081-1 | MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41082-9 | MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41083-7 | MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41084-5 | MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41085-2 | MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41086-0 | MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41087-8 | Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41088-6 | MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41089-4 | MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41090-2 | MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41091-0 | MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41092-8 | MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41093-6 | LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41094-4 | LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41095-1 | L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41096-9 | KEL gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
41097-7 | HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method |
41098-5 | GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41099-3 | GLA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41100-9 | GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41101-7 | GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41102-5 | GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41103-3 | Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41104-1 | GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41105-8 | FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41106-6 | FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41107-4 | FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41108-2 | FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41109-0 | FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41110-8 | CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41111-6 | COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41112-4 | CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41113-2 | Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41114-0 | CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41115-7 | NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41116-5 | ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41117-3 | AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41118-1 | AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41119-9 | APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41120-7 | ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41121-5 | ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41209-8 | VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method |
41210-6 | VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method |
41268-4 | VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method |
41294-0 | S-phase cells [Presence] in Unspecified specimen |
41743-6 | BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41748-5 | CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41749-3 | CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41750-1 | COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
41751-9 | COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41753-5 | FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41758-4 | GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41764-2 | SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41765-9 | SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41768-3 | VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
41872-3 | PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42179-2 | PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method |
42192-5 | Nidus [Presence] in Stone |
42209-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain |
42210-5 | Microscopic observation [Identifier] in Bronchial specimen by Cyto stain |
42240-2 | CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
42315-2 | APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42316-0 | RHD gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
42318-6 | GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42321-0 | HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42325-1 | RHD+RHC gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
42514-0 | Inhibin Ag [Presence] in Tissue by Immune stain |
42634-6 | 1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method |
42635-3 | Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method |
42660-1 | Alpha 2 laminin [Presence] in Tissue by Immune stain |
42712-0 | AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42713-8 | AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method |
42714-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
42715-3 | Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42777-3 | AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42778-1 | BRCA1 Ag [Presence] in Tissue by Immune stain |
42779-9 | BRCA2 Ag [Presence] in Tissue by Immune stain |
42780-7 | CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42782-3 | Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain |
42783-1 | ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42785-6 | FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42786-4 | HER3 Ag [Presence] in Tissue by Immune stain |
42787-2 | HER4 Ag [Presence] in Tissue by Immune stain |
42788-0 | Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain |
42789-8 | Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain |
42791-4 | Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain |
42792-2 | Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain |
42793-0 | Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain |
42794-8 | MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
42795-5 | Retinoblastoma protein [Presence] in Tissue by Immune stain |
42914-2 | HER2 [Mass/volume] in Serum by Immunoassay |
42938-1 | CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
42939-9 | CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
42940-7 | GALT gene allele 1 [Presence] in Blood by Molecular genetics method |
42941-5 | GALT gene allele 2 [Presence] in Blood by Molecular genetics method |
43097-5 | COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
43191-6 | FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43233-6 | OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43242-7 | ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43246-8 | PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43277-3 | GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
43306-0 | Chromosome 21 trisomy [Percentile] by Cytogenetics |
43310-2 | FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
43358-1 | UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
43368-0 | Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal |
43370-6 | CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method |
43399-5 | JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
43417-5 | Microscopic observation [Identifier] in Esophageal brushing by Cyto stain |
43427-4 | Microscopic observation [Identifier] in Tissue by Rapid stain |
43428-2 | Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain |
43585-9 | ECGF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43594-1 | Nidus [Mass] in Stone |
43744-2 | COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43745-9 | DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
43746-7 | KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43747-5 | OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
43748-3 | SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43749-1 | SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
43750-9 | SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
44419-0 | CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
44420-8 | CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
44421-6 | PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
44596-5 | IgG Ag [Presence] in Skin by Immunofluorescence |
44606-2 | ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
44608-8 | KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
44617-9 | PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
44618-7 | Total linear mm of carcinoma |
44619-5 | Length of tissue core(s) |
44623-7 | Matted nodes by CAP cancer protocols |
44624-5 | Additional pathological findings in Tumor |
44625-2 | Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols |
44626-0 | Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols |
44627-8 | Extraprostatic extension by CAP cancer protocols |
44628-6 | Reason specimen size cannot be determined in Breast tumor |
44629-4 | Specimen size.maximum dimension in Breast tumor |
44630-2 | Specimen size additional dimension 1 in Breast tumor |
44631-0 | Specimen size additional dimension 2 in Breast tumor |
44633-6 | Tumor pigmentation |
44634-4 | Reason invasive component size cannot be determined in Breast tumor Narrative |
44635-1 | Invasive component size.maximum dimension [Length] in Breast tumor |
44636-9 | Invasive component size additional dimension 1 [Length] in Breast tumor |
44637-7 | Invasive component size additional dimension 2 [Length] in Breast tumor |
44638-5 | Histologic type in Breast tumor |
44639-3 | Histologic type in Prostate tumor |
44640-1 | Histologic type in Skin melanoma |
44641-9 | Gleason pattern.primary in Prostate tumor |
44642-7 | Gleason pattern.secondary in Prostate tumor |
44643-5 | Gleason pattern.tertiary in Prostate tumor |
44645-0 | Nuclear pleomorphism in Breast tumor Qualitative by Nottingham |
44648-4 | Histologic grade [Score] in Breast cancer specimen Qualitative by Nottingham |
44649-2 | Grading system in Breast tumor |
44650-0 | Mitotic count per 10 HPF in Breast tumor |
44651-8 | Tissue cores.positive.carcinoma in Tissue core |
44652-6 | Total number of cores in Tissue core |
44653-4 | Tumor quantitation.incidental in Prostate tumor by CAP cancer protocols |
44654-2 | Tissue involved by tumor in Prostate tumor |
44655-9 | Number of carcinoma positive tissue chips CAP cancer protocols |
44656-7 | Number of tissue chips CAP cancer protocols |
44657-5 | Dominant nodule.maximum.dimension in Prostate tumor |
44658-3 | Dominant nodule additional dimension 1 in Prostate tumor |
44659-1 | Dominant nodule additional dimension 2 in Prostate tumor |
44660-9 | Tumor involvement by ulceration by CAP cancer protocols |
44661-7 | Depth of invasion by tumor [Length] in Skin melanoma |
44662-5 | Depth of invasion by tumor cannot be determined comment in Skin melanoma Narrative |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |